ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,226,831 | +60.8% | 113,788 | +31.1% | 0.66% | +58.2% |
| Q3 2022 | $1,385,000 | +132.4% | 86,785 | +232.6% | 0.42% | +210.4% |
| Q3 2020 | $596,000 | +61.1% | 26,090 | +47.6% | 0.13% | +48.9% |
| Q2 2020 | $370,000 | +26.3% | 17,680 | +48.6% | 0.09% | +233.3% |
| Q3 2018 | $293,000 | -0.3% | 11,897 | -20.6% | 0.03% | 0.0% |
| Q2 2018 | $294,000 | +4.6% | 14,982 | 0.0% | 0.03% | +3.8% |
| Q1 2018 | $281,000 | – | 14,982 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
| RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
| Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
| COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
| Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
| Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |